Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.

Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH.

Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):292-9.

PMID:
18090435
2.

Therapeutic potential of gamma-secretase inhibitors and modulators.

Imbimbo BP.

Curr Top Med Chem. 2008;8(1):54-61. Review.

PMID:
18220933
3.
5.

Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Davies NM.

Clin Pharmacokinet. 1995 Feb;28(2):100-14. Review.

PMID:
7736686
6.

Flurbiprofen.

Abdel-Aziz AA, Al-Badr AA, Hafez GA.

Profiles Drug Subst Excip Relat Methodol. 2012;37:113-81. doi: 10.1016/B978-0-12-397220-0.00004-0. Epub 2012 Mar 19. Review. No abstract available.

PMID:
22469318
7.

[Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly].

Orzechowska-Juzwenko K.

Przegl Lek. 1998;55(11):607-10. Review. Polish.

PMID:
10216376
8.
Items per page

Supplemental Content

Write to the Help Desk